文献速递产科母胎医学

先天性心脏病胎儿综合无创产前筛查的理论性能

Theoretical Performance of Comprehensive Non-Invasive Prenatal Screening in Congenital Heart Defects.
PubMed 文献 · Prenat Diagn · 2026-02-01

结果显示117例可被综合筛查识别,理论性能为76%,且在不同CHD亚型及是否合并心外异常间无显著差异。作者指出产前诊断仍是标准,筛查实际性能会低于理论值。

要点

  • 153例已知遗传诊断的CHD胎儿中,综合无创筛查理论可识别76%(117例)。
  • 致病诊断包括非整倍体37%、单基因病22%、CNV 18%、22q11.2缺失17%。
  • 理论性能在不同CHD亚型及有无心外异常间无显著差异。

核心结论

  • 在已知遗传原因的CHD胎儿中,现有筛查试验的优化组合理论上可识别最多76%的遗传原因,但临床实际性能会更低。
  • 产前诊断检测仍是胎儿异常的标准诊疗。

研究设计与样本

  • 通过判断哪些遗传诊断可被综合产前筛查各模式识别来计算理论性能。

主要发现

  • 153例中117例可被综合产前筛查识别,理论性能为76%。
  • 致病诊断构成:非整倍体37%、单基因病22%、CNV 18%、22q11.2缺失综合征17%、多重诊断6%、单亲二体1%。
  • 理论性能在不同CHD类别间及有无心外异常间无显著差异。

关键数值与推荐

  • 综合产前筛查包括携带者筛查及cfDNA检测非整倍体、22q11.2缺失综合征、>7Mb CNV和单基因病。
  • 153例中117例可识别,理论性能76%。

临床怎么用

  • 对拒绝产前诊断的CHD胎儿孕妇,可说明优化组合的现有筛查试验理论上最多可识别76%的遗传原因。
  • 咨询时应告知筛查实际性能会低于理论值,产前诊断仍是标准。

局限性

  • 理论性能基于已知致病遗传诊断的回顾性病例计算,临床实际性能会更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Comprehensive prenatal screening (CPS) (carrier screening and cfDNA for aneuploidy, 22q11.2 deletion syndrome, CNVs > 7Mb, and single gene disorders) can non-invasively identify genetic conditions in fetuses with congenital heart defects (CHD). We calculated the theoretical performance of CPS for CHDs with underlying genetic diagnoses. Secondarily, we compared theoretical performances across CHD subtypes and by the presence of extracardiac anomalies. METHODS: We retrospectively examined cases of fetal cardiac anomalies with known causative genetic diagnoses from January 2020 to October 2024. We calculated theoretical CPS performance by determining which genetic diagnoses were identifiable by CPS modalities. RESULTS: We extracted 153 fetuses with CHD and a known causative genetic diagnosis. Diagnoses included aneuploidies (37%), single gene disorders (22%), CNVs (18%), 22q11.2 deletion syndrome (17%), multiple diagnoses (6%), and uniparental disomy (1%). Of the 153 cases, 117 were identifiable by CPS, corresponding to a theoretical performance of 76%. Theoretical performances did not differ significantly across CHD categories or by the presence of extracardiac anomalies. CONCLUSIONS: Antenatal diagnostic testing remains the standard of care for fetal anomalies. Among individuals who decline diagnostic testing, our findings suggest that, in cases where a CHD has an underlying genetic cause, an optimal combination of currently available screening tests could theoretically identify up to 76% of genetic causes. However, actual performance will be lower in clinical practice.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Yang E, Bunnell ME, Adams S, et al. Theoretical Performance of Comprehensive Non-Invasive Prenatal Screening in Congenital Heart Defects. Prenat Diagn. 2026. PMID: 41622117. doi:10.1002/pd.70091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。